Director John M. Siebert to retire from Supernus Board at June 2024 annual meeting

SUPERNUS PHARMACEUTICALS, INC.

John M. Siebert, Ph.D., will retire from the Board effective at the Annual Meeting in June 2024.
Siebert will not stand for re-election; decision not due to any disagreement with the company.
Siebert served on the Board for over a decade.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John M. Siebert

Director

SUPN · SUPERNUS PHARMACEUTICALS, INC.

Filed: April 24, 2024, 7:59 PM ET

On April 22, 2024, John M. Siebert, Ph.D. informed Supernus Pharmaceuticals, Inc. (the “Company”) that he has decided to retire from the Company's Board of Directors (the "Board"), effective at the Company's Annual Meeting of Stockholders in June 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John M. Siebert retired as Director at SUPERNUS PHARMACEUTICALS, INC..

Action: retired
Role: Director

Exact text from the filing

On April 22, 2024, John M. Siebert, Ph.D. informed Supernus Pharmaceuticals, Inc. (the “Company”) that he has decided to retire from the Company's Board of Directors (the "Board"), effective at the Company's Annual Meeting of Stockholders in June 2024

View on SEC.gov

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-24-000020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.